204 related articles for article (PubMed ID: 20604972)
1. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
[TBL] [Abstract][Full Text] [Related]
2. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.
Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC
Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368
[TBL] [Abstract][Full Text] [Related]
3. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
[TBL] [Abstract][Full Text] [Related]
4. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
Liu C; Qu L; Dong B; Xing X; Ren T; Zeng Y; Jiang B; Meng L; Wu J; Shou C
Am J Med Sci; 2012 Apr; 343(4):295-302. PubMed ID: 22261620
[TBL] [Abstract][Full Text] [Related]
5. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Ann Surg Oncol; 2016 May; 23(5):1554-61. PubMed ID: 26759308
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of TSGF, CEA and AFP in patients before and after radical surgery for colon cancer.
Hu Y; Wang JL; Tao HT; Wu BS; Sun J; Cheng Y; Dong WW; Li RX
Asian Pac J Cancer Prev; 2013; 14(6):3877-80. PubMed ID: 23886200
[TBL] [Abstract][Full Text] [Related]
10. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
[TBL] [Abstract][Full Text] [Related]
12. Expression of γ-Synuclein in Bladder Carcinoma: A Possible Marker for Prognosis.
Chen Z; Ji Z; Wang Q; Shi B; Shou C; Liu C; Fan H; Li H; Davidson KT; Wakefield MR; Ball TW; Fang Y
Anticancer Res; 2016 Mar; 36(3):951-6. PubMed ID: 26976983
[TBL] [Abstract][Full Text] [Related]
13. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
15. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
16. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
17. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
19. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
20. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse.
Sinicrope FA; Hart J; Brasitus TA; Michelassi F; Lee JJ; Safa AR
Cancer; 1994 Dec; 74(11):2908-17. PubMed ID: 7954255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]